Flotillin-2 is associated with breast cancer progression and poor survival outcomesXi Wang(Key Laboratory of Guangdong Province), Huan-Xin Lin(Sun Yat-sen University)Journal of Translational MedicineAugust 15, 201310.1186/1479-5876-11-190Cited by 49SaveCiteExport RISWatch citationsRelated PapersEffect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment|JAMA|2020|229Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer|Frontiers in Immunology|2025|6